Figure 6.

The prognostic values of SOX11 in patients with breast cancer (BC). (a) SOX11 expression in BC tissues of different histological grades. (b) SOX11 expression in BC tissues of different Scarff Bloom and Richardson grade status (SBR). (c) The expression of SOX11 in ER‐positive and ER‐negative tumors. (d) The expression of SOX11 in several subtypes of patients with BC. (e and f) The high mRNA level of SOX11 was significantly associated with poorer OS and RFS in all patients with BC. (g) Immunohistochemical analysis of SOX11 in patients’ tissues. (h) The high protein level of SOX11 was significantly associated with poorer OS in all patients with BC. ER, estrogen receptor; HR, hazard ratio; IHC, immunohistochemistry; mRNA, messenger RNA; OS, overall survival; RFS, recurrence‐free survival